echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Study of Nervous System > JNNP: Application of psychotropic drugs and analgesics in patients with traumatic brain injury-a cohort study of 240,000 people in Sweden

    JNNP: Application of psychotropic drugs and analgesics in patients with traumatic brain injury-a cohort study of 240,000 people in Sweden

    • Last Update: 2021-03-21
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    medsci.


    cn/course/search.
    do?w=%E7%99%AB%E7%97%AB">medsci.
    cn/course/search.
    do?w=%E7%99%AB%E7%97%AB">Epilepsy In order to resolve the uncertainties in the use of psychotropic drugs and painkillers, this article investigated a group of people with traumatic brain injury.
    The drug use was compared with unaffected siblings.
    Such siblings provide a more effective control group than unrelated population controls because they have similar background characteristics (such as family history and common genetic and environmental factors).
    In order to resolve the uncertainty in the use of psychotropic drugs and analgesics, this article surveyed a group of people with traumatic brain injury.
    The drug use was compared with unaffected siblings.
    Such siblings provide a more effective control group than unrelated population controls because they have similar background characteristics (such as family history and common genetic and environmental factors).
    Diagnosis Although most people take opioids for a short period of time, one in five people use opioids for more than 6 months.
    Similarly, more than one-third of prescription benzodiazepines have been used for more than 6 months.
    To prevent complications caused by long-term use of opioids or benzodiazepines, postoperative review of these drugs should be routinely considered, including patients with mild TBIs, and other treatment strategies should be encouraged.
    MoleroY ,SharpDJ ,D'OnofrioBM MoleroY Molero SharpDJ Sharp D'OnofrioBM D'Onofrio , et albmj.
    com/content/early/2021/02/08/jnnp-2020-324353" target="_blank" rel="noopener">Psychotropic and pain medication use in individuals with traumatic brain injury—a Swedish total population cohort study of 240 000 persons Journal of Neurology, Neurosurgery & PsychiatryPublished Online First:09 February 2021.
    Published Online First: doi:10.
    1136/jnnp-2020-324353 doi: leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.